Cidara Therapeutics Stock (NASDAQ:CDTX), Quotes and News Summary

Q: What sector and industry does Cidara Therapeutics (CDTX) operate in?

Cidara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Cidara Therapeutics Stock (NASDAQ: CDTX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 696.678K
Day Range	- - -
52 Wk Range	0.593 - 1.480
Market Cap	$69.777M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	0.22%
Days to Cover	1

Recent News

Crude Oil Rises Over 1%; Cidara Therapeutics Shares Spike Higher

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Wednesday. The Dow traded down 0.57% to 34,443.02 while the NASDAQ fell 1.19% to 13,853.60. The S&P 500, also fell, dropping, 0.80% to 4,460.96.

Lisa Levin

Why Core & Main Are Trading Lower By 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 114% to $1.47. Palisade Bio transformed GI-focused pipeline through exclusive worldwide licensing agreement with Giiant Pharma, Inc. for multiple oral drug candidates targeting inflammatory bowel disease.

Lisa Levin

Why Is Infectious Diseases Focused Cidara Therapeutics Stock Trading Higher Today?

Cidara Therapeutics Inc (NASDAQ: CDTX) shares are trading higher after the company announced that Janssen Pharmaceuticals Inc, a unit of Johnson & Johnson (NYSE: JNJ), decided to pr

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Dec 23

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Cidara Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cidara Therapeutics (CDTX) stock?

You can purchase shares of Cidara Therapeutics (NASDAQ: CDTX) through any online brokerage.

View our list of the best stock brokerages.

Who are Cidara Therapeutics's (CDTX) competitors?

Other companies in Cidara Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), CARISMA Therapeutics (NASDAQ:CARM), Aligos Therapeutics (NASDAQ:ALGS), CollPlant Biotechnologies (NASDAQ:CLGN) and Ocean Biomedical (NASDAQ:OCEA).

What is the target price for Cidara Therapeutics (CDTX) stock?

The latest price target for Cidara Therapeutics (NASDAQ: CDTX) was reported by HC Wainwright & Co. on Monday, April 8, 2024. The analyst firm set a price target for 6.00 expecting CDTX to rise to within 12 months (a possible 679.22% upside). 14 analyst firms have reported ratings in the last year.

Current Stock Price for Cidara Therapeutics (CDTX)?

The stock price for Cidara Therapeutics (NASDAQ: CDTX) is $0.77 last updated April 18, 2024 at 7:59 PM EDT.

Does Cidara Therapeutics (CDTX) pay a dividend?

There are no upcoming dividends for Cidara Therapeutics.

When is Cidara Therapeutics (NASDAQ:CDTX) reporting earnings?

Cidara Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Is Cidara Therapeutics (CDTX) going to split?

There is no upcoming split for Cidara Therapeutics.

What sector and industry does Cidara Therapeutics (CDTX) operate in?

Cidara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-